IONOPTIX, LLC

Medtech · Private

Desktop instrument for high-throughput characterization of cardiac myocyte physiology via automated video imaging and fluorescence analysis

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $1.7M

Federal grants: $1.7M; 3 awards · 2017–2020; Rank in peer group#37 of 79
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 4; 1 pending · first 2016; Rank in peer group#7 of 79

Capital timeline

Latest events

Sep 2020Federal grantHealth and Human S · Phase II · High Throughput Screening of Pharmaceuticals Targeting Heart Cell Contractile Function$733K
Aug 2019Federal grantHealth and Human S · Phase II · High Throughput Screening of Pharmaceuticals Targeting Heart Cell Contractile Function$754K
Mar 2017Federal grantHealth and Human S · Phase I · High Throughput Screening of Pharmaceuticals Targeting Heart Cell Contractile Function$205K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 79 peers

Line = median

Medtech · Instrument

Federal grants#37 · top 47%
Granted patents#7 · top 9%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 5

Sep 24, 2019GrantedApparatus and Method for Culturing Cells and TissueUSPTOUS 10,421,955
Mar 26, 2019GrantedCell Grabber with Unitary ConstructionUSPTOUS 10,241,016
Apr 11, 2017GrantedApparatus And Method For Culturing Cells And TissueUSPTOUS 9,617,507

Show all 5 patent records

Apparatus and Method for Culturing Cells and TissueSep 24, 2019 · US 10,421,955Granted
Cell Grabber with Unitary ConstructionMar 26, 2019 · US 10,241,016Granted
Apparatus And Method For Culturing Cells And TissueApr 11, 2017 · US 9,617,507Granted
Cell Grabber with Unitary ConstructionAug 30, 2016 · US 9,429,560Granted
Apparatus and Method for Culturing Cells and TissueApplication 61717987Pending

SPINHANCE, LLCSimilar federal contract value in Medtech · null in contracts
REMASTERED SLEEP LLCSimilar federal contract value in Medtech · null in contracts
PHD SKIN CARE LLCSimilar federal contract value in Medtech · null in contracts
PATHWARE INC.Similar federal contract value in Medtech · null in contracts
Prehensile TechnologiesSimilar federal contract value in Medtech · null in contracts
PULSAR LIFE SCIENCES, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.